Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,531.9
-13.6 (-0.53%)

 

  • STI Straits Times Index
    2,531.9
    -13.6 (-0.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,570.9
    -0.8 (-0.05%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,779.6
    402.1 (1.65%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,352.2
    -27.0 (-0.80%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,750.2
    420.3 (1.88%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,188.3
    30.5 (0.59%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,000.2M
  • Value: 1,146.4M
  • Rise: 143
  • Fall: 175
  • Unch: 491

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.019+0.002
Oceanus^0.008-
ISDN0.430+0.035
ThaiBev0.605-
Polaris0.002-0.001
Keppel Corp4.810-0.590
Genting Sing0.670-0.010
Intl Cement0.042+0.017
Singtel2.360-0.020
China Real Estate0.002-

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

KINTOR PHARMA-B KINTOR PHARMA-B
Quotes 15 Minutes Delayed. Updated at 11 Aug 2020 14:47
Last (HKD): 15.420 Change: -0.300 High: 15.960 Remarks: -
Change (%): -1.91 Low: 15.400
Open 15.860 Yesterday's Close 15.720
Buy Price 15.420 Sell Price 15.440
Buy Volume ('000) 29 Sell Volume ('000) 3.5
Cumulative Volume ('000) 358.5 Cumulative Value 5,580,660
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a -0.62962 Trailing EPS (HKD) e -0.62962 NAV (HKD) b 1.0007
PE a - Trailing PE f - Price / NAV b 15.4092
Dividend (HKD) d - Cash In Hand (HKD) g 0.5293 Issued & Paid-up Shares c 369,390,000
Dividend Yield (%) d - Price / Cash In Hand g 29.133 Treasury Shares h -
Beta - 75 Daysi 0.466 R-Squared - 75 Days(%)i 1.30 Market Cap (M) 5,695.994
Beta - 500 Daysi 0.468 R-Squared - 500 Days (%)i 1.29 Enterprise Value (M) 5,564.559
Piotroski F Score 2 Exchange Code 9939 Par Value ( USD ) 0.00010
52 Weeks Volatility (%) n.a. 6-Month VWAP n.a. Free Float (%) 91.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 22 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 15 May 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference KINTOR PHARMA-B HKEx 5,695.994 - - 15.4092 -
Industry Biotechnology HKEx 58,074.751 22.746 26.538 6.7080 2.203
Local Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Local Peer WUXI BIO HKEx 219,326.144 190.790 190.790 15.3369 -
Local Peer SINO BIOPHARM HKEx 174,571.550 56.878 57.398 5.0387 0.574
Local Peer BEIGENE HKEx 149,440.925 - - 7.6022 -
Local Peer GENSCRIPT BIO HKEx 30,706.750 - - 10.2947 -
Local Peer 3SBIO HKEx 22,968.256 20.803 20.802 2.1333 -
Local Peer HAOHAI BIOTEC HKEx 18,609.606 44.263 44.263 3.1639 0.732
Local Peer VIVA BIOTECH HKEx 18,951.135 62.862 62.861 9.5319 0.165
Local Peer ALPHAMAB-B HKEx 15,159.472 - - 5.5865 -
Local Peer ASCENTAGE-B HKEx 7,802.985 - - 7.8337 -
Local Peer FRONTAGE HKEx 7,807.795 54.062 54.064 3.7870 -
Local Peer LEE'S PHARM HKEx 3,552.275 28.293 28.293 1.5472 0.927
Other Local Peers SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), BIOSINO BIO-TEC (HKEx), REGENT PACIFIC (HKEx), HAO WEN H-NEW (HKEx), HAO WEN H-OLD (HKEx)
Global Peer AMGEN INC NASDAQ 139,494.740 17.788 19.111 13.0871 2.459
Global Peer CSL ASX 126,915.776 47.305 43.813 14.6750 0.949
Global Peer GILEAD SCIENCES INC NASDAQ 85,892.357 15.947 - 4.7647 3.714
Global Peer VERTEX PHARMACEUTICAL NASDAQ 69,995.297 59.479 33.639 9.3088 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 64,711.852 30.585 21.690 7.1446 -
Global Peer ILLUMINA INC NASDAQ 51,589.100 51.486 74.953 11.3834 -
Global Peer BIOGEN INC NASDAQ 47,535.061 8.073 8.020 4.2034 -
Global Peer MODERNA INC NASDAQ 28,414.210 - - 9.5013 -
Global Peer SEATTLE GENETICS INC NASDAQ 27,439.327 - - 15.1258 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,329.345 9.287 26.391 2.1285 -
Other Global Peers BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), NOVAVAX INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), EXELIXIS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), Lonza (SGX), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), FIBROGEN INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), FATE THERAPEUTICS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), ALLOVIR INC (NASDAQ), KODIAK SCIENCES INC (NA